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Summary 
In male mice that express a transgenic cr  T  cell receptor (TCR) specific for a male-specific 
peptide presented by class I D b major histocompatibility complex (MHC) molecules, we describe 
an unusual lineage of ol/3 T  cells that are thymus dependent but do not require selection by 
D b MHC  molecules on  thymic epithelium  in  the absence of the  specific  peptide  (positive 
selection). These cells express the transgenic ce/3 TCR and have the CD4-8-  or CD4-8 l~ 
phenotype. Cells with the latter phenotype are only detected when hemopoietic cells express 
both the male-specific peptide as well as D b MHC molecules. In fact, these cells are autoreactive, 
as they expand relatively slowly after transfer into male nude mice. Also in male but not female 
oL//~ TCR transgenic mice, the CD8 + cells with the transgenic TCR bear the Pgpl marker 
characteristic of mature T cells activated by antigen. CD4-8-  as well as CD4-8 l~  cells do not 
respond significantly when cultured with male stimulator cells but proliferate vigorously when 
stimulated by TCR antibodies. By this latter criterion, cells in the periphery of male ol/~ TCR 
transgenic mice differ from mature male-specific T cells from female c~/~ TCR transgenic, which 
become intrinsically anergic when transferred into male nude mice and cannot be stimulated 
significantly by TCR antibodies. Thus, intrathymic deletion does not eliminate all autoreactive 
T  cells and it is possible that cells with an apparently "benign" autoreactivity may be involved 
in certain forms of autoimmunity. 
series of experiments in TCR. transgenic as well as normal 
mice has delineated a maturation pathway of developing 
T  cells that includes the selection of cells according to the 
specificity of their receptor for antigen (reviewed in refer- 
ences 1 and 2).  It has been established that the maturation 
of o~/3 T cells that express normal levels of CD4 and CD8 
coreceptors requires the binding of the o~/3 TCR to thymic 
MHC ligands. This has been most clearly shown in TCR 
transgenic SCID mice (3), as well as in mice that lack class 
I (4) or class II MHC molecules (5). This selection step does 
not require the presence of the specific peptide recognized 
by the TCR but does require the presenting MHC mole- 
cule, probably occupied by some other peptide on thymic 
epithelial cells (6-8).  Another selective  step that occurs in 
the presence of both the specific peptide as well as the pre- 
senting MHC molecule is the deletion of developing T cells 
that express the relevant TCR (9-11).  For deletion to occur, 
it is suffcient that the complete ligand is expressed by cells 
of hemopoietic origin (1). 
When analyzing TCR transgenic mice expressing a TCR 
specific for male-specific (HY) peptides presented by class I 
D b MHC  molecules,  we  were  surprised  to  find  normal 
numbers of Thy-l-positive cells  in  the periphery of male 
H-2  b mice, even though their thymus was very small (11). 
Moreover, we showed that most of the peripheral T cells in 
these mice were either CD4-8-  or CD4-8 l~  with very 
few CD4 +  8-  T  cells present in lymph node and spleen. It 
turned out that the vast majority of the peripheral T  cells 
expressed the transgenic TCR consisting of transgenic /3T 
and OtT TCR chains,  while the few CD4+8-  T  cells  ex- 
pressed j3a-OeE  receptors, due to the lack of "allelic exclusion" 
of TCRoe chains in TCR transgenic mice (1, 12). The origin 
of the CD4- 8- and CD4- 8  I~  j3TOIT cells in these mice was 
not obvious: one possibility was that these cells had escaped 
negative selection in the thymus, undergone positive selec- 
tion, and on confrontation with the male-specific  peptides 
presented by D b MHC  molecules in peripheral lymphoid 
tissue,  had downregulated their CD8 coreceptor molecules. 
An alternative possibility was that some of these cells had 
intrinsically low levels of coreceptor molecules suffciently 
high for positive but insufficiently high for negative selec- 
tion, and that cells with this phenotype had expanded con- 
siderably in  the periphery of male H-2  b TCR  transgenic 
mice. A third possibility was that T  cells with this pheno- 
type represented a distinct lineage of c~/j3 T cells that could 
accumulate in peripheral lymphoid organs. 
To discriminate between the various possibilities,  we con- 
ducted experiments on the origin and selection of CD4- 8- 
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tigens.  Our  experiments  show  that  the  CD4-8-  and 
CD4-8 +low T  cells represent a thymus-dependent popula- 
tion of T cells that does not require positive selection by MHC 
molecules on thymus epithelium. Also, these cells are not 
susceptible to deletion. On the contrary, the CD4-8 l~  cells 
appear to be activated and expanded in vivo by hemopoietic 
cells expressing both the specific peptide as well as presenting 
MHC molecules. While these cells appear unreactive in vitro, 
their expansion potential can be revealed by transfer in adop- 
tive  hosts.  Because  of this  anomalous behavior  and  the 
similarity to some T  cells found in autoimmune strains  of 
mice, we think it possible that T cells of this unusual lineage 
could be involved in certain forms of autoimmunity. 
Materials  and Methods 
Mice.  The ed3 TCR transgenic mice were described  previously 
(11). B10.D2 mice were obtained from the animal colony of the 
Basel Institute for Immunology. CD57B1/6 nude mice were ob- 
tained from the CNRS, Centre de s61ection  de d'61evage  d'animaux 
de laboratoire (Orl6ans, France). 
Bone Marrow Chimeras.  Female  B10.D2 recipient mice were 
lethally X-irradiated with 950 rad. Afterwards, the mice were in- 
jected intravenously with 107 T-depleted bone marrow cells from 
either female or male cr  TCR transgenic H-2  b SCID mice (3). 
Injection into Nude Mice.  5.5  x  106  spleen cells from male 
C57B1/6 Thy-l.1 c~/~ TCR transgenic mice were depleted of slg- 
positive B cells and injected intravenously into either male or fe- 
male C57B1/6 Thy-l.2 nude mice. The absolute number of recov- 
ered T cells of different phenotypes recovered from the recipient 
spleen at different timepoints after transfer was calculated as de- 
scribed previously (13, 14). 
Purification of Cells Expressing the Transgenic TCR from  Various 
Mice.  Cells  from lymphoid organs were stained with monovalent 
Fab fragments of the T3.70 mAb directed against the TCR o~ chain 
of  the transgenic  TCR. These fragments  were  coupled  with carboxy- 
fluorescein-N-hydroxysuccinimide  ester (FLUOS) and because of 
their monovalent nature did not induce proliferation of T cells. 
The stained cells were purified by cell sorting and subsequently 
cultured with various stimulator cells or TCR antibodies. 
In Vitro Proliferation.  Various numbers of responder cells were 
cultured with 1-5  x  105 X-irradiated (2,500 rad) female or male 
spleen cells from nude mice. Cultures were set up either in the 
presence or absence of  exogenous interleukin 2 (15). Some cultures 
contained 10/~g of the T3.70 antibody directed against the trans- 
genic c~ TCR chain (16) in addition to female spleen cells from 
nude mice. 
Antibodies.  For cell surface staining, we used CD4 (No. 1447; 
Becton Dickinson & Co., Mountain View, CA) (PE-coupled or 
GK1.5 [17] FITC-conjugated), CD8o~ (No. 1353; Becton Dick- 
inson & Co., fluoresceine  conjugated), T3.70 anti-TCR c~ chain 
(18), CD83 (31.1.1) (19), and Pgpl  (CD44) (20) antibodies. 
Surface Staining.  5  x  104 up to 5  x  106 lymphocytes were 
pelleted in round-bottomed wells of 96-weU microtiter plates. Cells 
were resuspended in 50 #1 of PBS containing the described anti- 
bodies in optimal concentrations and incubated for 15 min on ice. 
After incubation, cells were washed twice in PBS containing 2% 
FCS and resuspended either in 100/zl of the same solution (in case 
of direct staining) or in 50/~1 of PBS containing PE-streptavidine 
(Southern Biotechnology Associates, Inc., Birmingham, AL) and 
incubated for further 15 min on ice. After washing, the cells were 
analyzed on a FACScan  | 
Results 
The CD4-8-  and CD4-8 uw 0./3  T  cells in  TCR  Trans- 
genic  Mice Are  Thymus  Dependent.  To  find out  whether 
Thy-1 +, CD4-8-, and CD4-8  l~  T cells expressing a trans- 
genic c~/3  TCR  are  thymus dependent, we crossed  H-2  b 
cr  TCR  transgenic mice with H-2  b nu +/nu-  mice and 
crossed the resulting F1 generation back with H-2  b nu +/nu- 
mice. Male and female nu § mice harboring the TCR trans- 
genes were selected from the backcross generation, and cells 
from peripheral lymphoid organs as well as bone marrow 
were analyzed. As shown in Fig. 1, the staining of various 
cells with CD4, CD8, and T3.70 (anti-c~T) antibodies was 
not different from that obtained with cells from nontrans- 
genic nu + mice.  This indicates that rearranged TCR genes 
present in the germline cannot bypass the requirement of a 
thymus in the development of c~/3 T ceils that are normally 
present in the spleen, axillary, and inguinal lymph nodes and 
bone marrow of mice.  In addition, we conclude that o~/3 
T cells with the abnormal CD4-8-  and CD4-8 l~  pheno- 
type,  which  are  predominant in  male H-2D  b c~/3  TCR 
transgenic mice, are also thymus dependent, since we do not 
detect significant numbers of these cells in male TCR trans- 
genic nu + mice. 
CD4-8-  0./3  T  Cells Do Not Require Positive Selection by 
Thymic MHC Molecules.  We have reported previously that 
we could detect CD4-8-  0./3 T cells bearing the transgenic 
TCR  in  peripheral  lymphoid organs  of H-2  d c~/~  TCR 
transgenic SCID mice, indicating that these ceils do not re- 
quire positive selection  by thymic H-2D  b MHC molecules 
(3). This finding could be reproduced in hemopoietic X-ir- 
radiation chimeras constructed by injecting T cell-depleted 
bone marrow from female H-2  d/b or male H-2  d/d OL/~ TCPx 
transgenic SCID mice into female lethally X-irradiated B10.D2 
(H-2  a) recipient mice. Fig. 2 (middle and bottom) shows that 
in this transfer experiment, host cells of hemopoietic origin 
survived the X-irradiation and reconstituted the lymphnodes 
of recipient mice to some extent. It is also clear  that ceils 
that expressed the transgenic TCR were present in periph- 
eral lymph nodes. These cells expressed neither CD4 nor CD8 
coreceptors in contrast to 3TC~T ceils in male H-2  b oe/3 TCR. 
transgenic mice,  which were comprised of both CD4-8- 
as well as CD4-8  l~  cells. This raised the possibility that the 
latter population was dependent on the presence of both the 
male-specific  peptide  as well as  the presenting D b MHC 
molecules. 
CD4- 8  l~  o./3 T  Cells Are Selected by Nominal Antigen on 
Hemopoietic Cells.  To test whether the presence of CD4- 8  l~ 
~TO~T T  cells required selection by H-2D  b MHC molecules 
on thymic epithelial ceUs and/or the presence  of nominal 
antigen  on  hemopoietic  cells,  we  prepared  hemopoietic 
X-irradiation  chimeras by injecting T  cell-depleted bone 
marrow cells from male H-2  d/b c~/3 TCR transgenic SCID 
mice into lethally X-irradiated B10.D2 recipients.  In this sit- 
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Figure  1.  Staining  of lymph node 
and bone marrow cells from male H-2  b 
~/~ TCR transgenic  mice (od/~ o'; left), 
from male H-2  b c*//~ TCR transgenic 
nu/nu mice (oe//~ nu/nu CY; middle), and 
male C57B1/6  nude mice (nu/nu  o'; 
right)  by CD8 and T3.70 (transgenic 
TCR ~ chain) antibodies. Numbers in 
quadrants represent the proportion of 
all gated cells in each quadrant. 
uation, the developing T  cells do not encounter D b MHC 
molecules on epithelial cells in the thymus but do encounter 
nominal antigen presented by D b MHC molecules on cells 
of hemopoietic origin. As shown in Fig. 2 (top), the presence 
of the male peptide on hemopoietic cells was responsible for 
the appearance of CD4-8 l~  3TaT T cells, which could not 
be detected in B10.D2 recipient mice reconstituted with bone 
marrow from female H-2  b/d or male H-2  ale ce/[3 TCR trans- 
genic SCID  mice (Fig.  2).  This indicates that  CD4-8 l~ 
BXOtT cells like CD4-8-  /JTCeT cells are generated indepen- 
dently of positive selection by D b MHC molecules on thy- 
mus epithelium but require selection by the complete ligand, 
i.e.,  the specific peptide and presenting MHC molecules on 
hemopoietic cells. This may be so either because the com- 
plete ligand induces the expression of CD8 coreceptor mole- 
cules and/or because it induces the expansion of CD4- 8  l~ 
cells. 
CD4-81~ Cells Can Expand upon Transfer into nu + Mice. 
To test whether T calls with the transgenic c~/3 TCR would 
expand in vivo, we transferred T calls from male H-2  b or/3 
TCR  transgenic mice into  male H-2  b nu + recipient mice 
(Fig.  3).  As observed in previous experiments (13), T  cells 
expressing endogenous TCR ol chains and normal levels of 
CD8 molecules grew rapidly after transfer and did not ex- 
pand after reaching maximal levels 1-2 wk after injection (13; 
and  data  not  shown).  In  contrast,  CD4-8 l~  3XOtT cells 
grew very slowly.  1-2  wk after injection,  the number of 
CD4-8 jow ~TO~T  cells in the spleen of recipient mice was 
similar to the number of injected calls with that phenotype. 
From  then  on,  the  number  of CD4-8 l~  3T~T  cells  in- 
creased progressively. Further expansion could be observed 
when CD4-81~  BxoeT were collected 3 mo after the first 
transfer and were injected again in male nu + mice (Fig. 3). 
In contrast, CD4-8-  ~TO/T  showed no expansion potential 
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in the same assay (data not shown). These results indicate 
that CD4-8 t~  BTOeT cells are capable of significant expan- 
sion in vivo but that their expansion has much slower ki- 
netics than that of 3XOeT CD8 + cells from female o~/~ TCR 
transgenic mice and that of 3Toer or 3EC~ CD8 + cells from 
either male or female el~[3 TCR transgenic mice (13). 
CD4-8  l~  [3rOeT T  Cells May Be Derived from  CD4-8- 
3rotr Precursors.  We prepared CD4-8-  3TORT T cells from 
male H-2D  b oL/3 TCR transgenic mice by rigorous deple- 
tion of cells expressing CD8 coreceptors. When these cells 
were propagated in vitro by stimulation with T3.70  anti- 
bodies and II:2,  no CD8 + cells were recovered after 1 wk 
of culture (Fig. 4). However, when such cells were not cul- 
tured,  but  injected into  male nu + recipients,  and  lymph 
nodes were analyzed 2-7 wk weeks after the injection,  a 
significant number of CD4- 8  ~~  T cells that bore the trans- 
genic TCR were detected (Fig.  5). While this result is con- 
sistent with  a precursor-product relationship of CD4-8- 
and CD4-8 l~  ~TO~T  T calls, we can at the present time not 
exclude the possibility of selective expansion of a very minor 
contaminant present in the inoculum. 
The Surface Phenotype of CD4-8  l~  ~T~T T  Cells in Male 
1-I-2  b o./~ TCR Transgenic Mice  If CD4- 8  l~  3TCrT T cells 
were indeed antigenically stimulated cells,  one might ex- 
pect to find markers typical for activated or memory T cells 
like Pgpl (CD44) (20). As shown in Fig. 6, many CD4-8 l~ 
T  cells  are  in  fact  Pgpl  positive,  while  CD4-8 +  ~TC~T 
cells from female oe/3 TCR transgenic mice are Pgpl nega- 
tive (Fig.  6) and remain negative when they are transferred 
into female but not male H-2  b nu +/nu + mice (our unpub- 
lished results). This may suggest that the Pgpl expression 
of CD4-8 + T  cells results from antigenic stimulation.  It 
was also interesting to see whether CD4-8 l~  T  cells were 
expressing CDSc~ homodimers rather than CDSer  hetero- I C~ H-2b~IB TCR SCID bone marrow-  ~ BIO. D2 I 
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Figure 2.  Staining of lymph node cells by CD8 and T3.70 (transgenic 
o~ TCR chain) antibodies 2 mo after reconstitution of lethally X-irradiated 
female B10.D2 recipients with T cell-depleted bone marrow cells from 
either male (top) or female (middle)  H-2  d/b or male H-2  d/d (bottom)  oz/B 
TCR transgenic SCID/SCID donor mice. The T3.70-negative CD8 + and 
CDS- cells are mostly derived from the X-irradiated host as defined by 
staining with H-2  d and H-2  b antibodies (data not shown).  The experi- 
ment shown at the bottom was done on a different day, hence the slight 
difference in the intensity of staining. 
dimers in light of the finding that "activated" 3,/6 T  cells 
express predominantly CD8ot homodimers. As shown in Fig. 
7,  this is not the case for CD4-8 l~  T  cells that do 
express some very reduced levels of CDS~ proteins on the 
cell surface. 
CD4-8-  and CD4-8 t~ Cells from Male o~/~ TCR  Trans- 
genic Mice Are Not Intrinsically Anerg~  In recent experiments, 
we have shown that mature malespecific CD4-8 + OtT~T T 
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Figure 3.  Expansion of CD4-CD8  l~  T  cells from male a/B TCR 
transgenic mice after transfer into male nu + mice. R~sults represent the 
absolute number (x  10 -6) of donor cells of each phenotype recovered in 
recipient spleen at different time points after transfer. The are the mean 
of two (1 wk and 2 mo after first transfer, all time points of second transfer) 
and four (3 mo after first transfer) mice in each group. (.4) First transfer: 
spleen cells from Tby-L1 male ot/~ TCIk transgenic mice were injected 
intravenously into Thy-l.2 male nu +  mice. The number (x  10-6)  of 
donor cells of each phenotype injected simultaneously in each recipient 
was: CD4-8- aT, 2.3; CD4-8  [~  aT, 1.4; CD4-8 + aE, 0.7. (B) Second 
transfer: Thy-l.1 donor cells were recovered from the hosts 3 mo after 
the first transfer and injected into a second set of male nu +  recipients. 
The number (x  10 -6) of donor cells of each phenotype injected simul- 
taneously into each recipient were: CD4-8-OtT, 0.05; CD4-8  l~ OtT, 0.9; 
CD4-8 +  o~E, 0.2.  CD4-8-~T  cells did  not  expand  in any of the 
recipients and are therefore not shown. 
cells from female transgenic mice proliferate strongly when 
injected into male but not female nu + recipients such that 
after 5 d, the recovery  of malespecific cells from male recipients 
is 50 times that from female recipients. Thus, the male-specific 
proliferation detected in vitro in the presence (see Table 2) 
or absence (13) of exogenously added II.-2 is reflected in a 
significant expansion potential in vivo. We observed that after 
the initial wave of proliferation, the number of male-specific 
~TOLT cells decreased in the male nu + recipients and that the 
remaining cells with the transgenic TCR became refractory 
to antigenic stimulation in the presence or absence of exoge- 
nous IL-2. We wanted to compare the functional capabilities 
of T cells with the transgenic receptor obtained from male 
nu + mice injected with T cells from female transgenic mice 
and the T  cells present in the periphery of male transgenic 
mice in order to see whether the different selection of these 
cells was also reflected in a different functional phenotype. 
As shown in Tables  1-3, this is clearly the case:  to obtain 
the same number of cells with the transgenic TCR from male 
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Figu~ 4.  Propagation  of  T cells  from 
female  H-2  b ~/~ TCR transgenic  mice 
(Is  from  male  H-2  b (x//5 TCK trans- 
genic mice (m~le), and from male mice 
after depletion ofCD8 + cells  by T3.70 
antibodies and IL-2 in culture. Cells 
were stained  after I wk in culture  with 
CD8 antibodies.  Numbers represent the 
proportion of all gated  cells in the var- 
ious fractions. 
Figure S.  Staining  of lymph node 
cells from male H-2  b ~//~ TCR trans- 
genic mice (/eft) and from male H-2  b 
nude mice at day 15 (middle) and day 
41 (right) aftez  injection  with CD4-8- 
T  cells from male H-2b c~//3 TCR 
transgenic mice with CD8 and T3.70 
(transgenic ~ TCR chain) antibodies. 
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Figure 6.  Staining  of lymph node T cells from male and female H-2  b 
c~//3 TCR transgenic  mice with CDS, T3.70 ((XT = antibody  directed 
against the transgenic  TCR c~ chain) and Pgpl antibodies. Cell suspen- 
sions were depleted of CD4* cells before the analysis. 
or female nu + mice injected with T cells from female trans- 
genic mice, the cells were stained with a monovalent FITC- 
conjugated Fab fragment of the T3.70 TCR antibody. This 
fragment did not induce any measurable activation of T cells 
expressing the transgenic TCR. The T3.70-positive cells were 
sorted and stimulated in culture either with antigen (male 
spleen cells) or the T3.70 antibody. It can be seen in Table 
1 that sorted cells from female nude mice injected with lymph 
node cells from female o~//~ TCR transgenic mice responded 
with proliferation when stimulated by male antigen or T3.70 
and CD3 antibodies. The stronger response to the antibodies 
is probably due to the high affinity of the antibodies to the 
TCR while the receptor may have relatively low affinity for 
male antigen (which, however, is sufficient to lead to mas- 
sive clonal expansion in vivo). In contrast, ceils recovered from 
recipient male mice did not respond significantly to male 
stimulator cells and also their response to TCR and CD3 
antibodies was greatly diminished. This indicates that the 
latter cells  are  intrinsically anergic.  In contrast,  CD4-8- 
and CD4-8 l~  ceils from male c~//3 TCR transgenic mice 
have a different functional phenotype (Table 2): while they 
do not proliferate when stimulated by male antigen,  they 
proliferate vigorously when stimulated by TCR antibodies, 
i.e., they are not intrinsically anergic because their responses 
to stimulation by TCR antibodies is very similar to that of 
calls from female oe//3 TCR transgenic mice even when the 
dose of TCR antibodies is varied (Table 3). 
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Table  2.  CD4-8-  and CIM-8 ~  ~'r,~r Cells from  Male 
Transgenic Mice Are Not Anergic 
R.esponders 
Stimulators*  e~/IS q  a/IS o'  o~/IS cr 
(X-irradiated)  CD8 +  CD8-  CD8  l~ 
c~m 
nu/nu  Q  500  400  300 
nu/nu  Cr  13,200  500  300 
nu/nu  Q  +  T3.70  105,000  80,000  81,000 
5  x  104 lymph node cells from either female or male C57B1/6 c~/13 
TCR transgenic mice were cultured with various stimulator ceils and 
antibodies. CDS- and CD8 I*w T cells from male a//3 TCR transgenic 
mice were obtained by staining the cells with the FITC-conjugated  53-6.7 
(anti-CDS) antibody and sorting the cells. The data shown here are 
representative of five independently carried out experiments. 
* All cultures contained IL-2 (15). 
Figure 7.  Staining  of  lymph node cells from female (left) and male (right) 
c~/~ TCR transgenic mice with CD4, CD8c~, and CD8B antibodies. 
Table  1.  Intrinsic Anergy of CD4-8 § I~T~T Cells after 
Confrontation with Antigen 
Responders 
Stimulators  nu/nu  Q recipients  nu/nu  cy recipients 
cpm 
nu/nu  C2  200  150 
nu/nu  O'  7,350  300 
nu/nu  q  +  T3.70  81,850  2,250 
nu/nu  Q  +  CD3  82,000  5,700 
107 lymph node cells from female C57B1/6 (~/B TCK transgenic mice 
were injected intravenously  in either female or male C57B1/6 nu/nu mice. 
After 2 wk, single cell suspensions from lymph node and spleen were 
prepared, depleted of B cells (alg-coupled dynabeads), and stained with 
FITC-conjugated Fab fragments of the T3.70 (anti-aT) antibody as well 
as PE-coupled L3T4 (anti-CD4) antibodies. CD4-, T3.70 + cells were 
sorted, and 7 x  103 cells were cultured with 10  s various stimulator cells 
and antibodies. Responses to male stimulator cells were obtained in the 
presence (above) or absence of exogenously added IL-2 (12), and were 
in the same order of magnitude. The TCR transgenes were derived from 
the B6.2.16 clone, which  showed a strong male-specific proliferative 
response but relatively weak male-specific killing (<30%),  presumably 
because of a relatively low affinity  of the TCR. The same level of killing 
is observed with lymph node cells from female or//3 TCR transgenic mice 
when stimulated with male cells, and for this reason, we only provide 
data on proliferative responses. The data shown here are representative 
of three independently carried out experiments. 
* All cultures contained IL-2 (15). 
Discussion 
The lineage of c~/~ T cells described in this report is different 
from that which undergoes positive selection in the thymus 
and contains  mature T  cells  that  can become intrinsically 
anergic when confronted with antigen in peripheral lymphoid 
organs (13): the CD4-8-  and CD4-8 l~  cells expressing a 
male-specific TCR in male o~/fl  TCR transgenic  mice ap- 
pear not to undergo positive selection induced by D b MHC 
molecules on thymic epithelium  and  have not become in- 
trinsically anergic on contact with male antigen in periph- 
eral lymphoid organs. Rather, the CD4-8 l~  cells appear to 
Table  3.  [~To~T Cells from Female and Male (x/IS Transgenic Mice 
Respond to Similar Doses of Receptor Antibodies 
Responders 
Stimulators  c~/is ~  c~/is o" 
nu/nu  Q  1,800  900 
nu/nu  o"  15,300  1,200 
nu/nu  Q  +  T3.70 
4 ng/ml  51,000  80,000 
15 ng/ml  68,000  100,000 
60 ng/mt  86,000  129,000 
250  ng/ml  103,000  141,000 
1,000 ng/ml  111,000  149,000 
4,000 ng/ml  105,000  135,000 
5  ￿  104 CD4-  and slg-depleted spleen and lymphnode cells from fe- 
male and male c~/B TCR transgenic mice were cultured with 3.5  x  105 
X-irradiated (2,200 rad) female or male nu + spleen cells or with the 
former and various concentrations of the T3.70 antibody. All cultures 
contained IL-2 (15). 
1006  Unusual Lineage of ot/B T Cells be antigenically stimulated and their (relatively slow) expan- 
sion potential  in response to male antigen  can be revealed 
in vivo but not in vitro.  Thus,  these cells show some "be- 
nign" autoreactivity in vivo, and one may wonder whether 
this can develop into a more malicious form when,  for in- 
stance, in a certain microenvironment lymphokines upregu- 
late the level of antigen or upregulate the effector function 
of these autoreactive T  cells. 
The lineage of c~/3 T  cells described in this report does 
not appear to be an artifact observed only in oe/B TCR trans- 
genic mice for the following reasons. The CD4-8-  T  cells 
correspond very dosely to a population of ot/B T  calls de- 
tected in the thymus of normal mice with regard to surface 
markers, functional phenotype, appearance during ontogeny, 
and expression of autospecific receptors.  In normal mice as 
well as or~3 TCR transgenic  mice,  cr  CD4-8- 
cells lack Jlld surface molecules and are readily induced to 
proliferation by lectins or antireceptor  antibodies.  In both 
types of mice, these cells develop relatively late during on- 
togeny (16, 21), i.e.,  around birth, and they can express au- 
tospecific TCRs. It would appear from our results that these 
cells do not require positive selection by MCH molecules on 
thymic epithelium. Also, cells with this phenotype may take 
part in lymphoproliferation in the gld and llor autoimmune 
strains. 
We think it is possible that the CD4-8 l~  cells are prod- 
ucts of CD4-8-  precursors and that they are selected when 
both the specific peptide and the presenting MHC molecules 
are present. It is also possible that these ligands induce CD8 
expression.  We cannot  detect such precursor-product  rela- 
tionship in vitro after stimulation with TCR antibodies, but 
we are detecting CD4-8 h'* cells several weeks after injection 
of CD4-8-  T  cells  into  male nu + mice.  These cells  bear 
markers (Pgpl) that are believed to be the result of antigenic 
stimulation  while the CD4-8-  T  cells  do not. 
The origin of this lineage of a/B T  cells remains obscure 
at present.  One of us has speculated (1) that  these cells are 
in fact cells of the 3~/t~ lineage that may occasionally express 
oe/~ TCRs due to some leakiness in the mechanisms con- 
trolling their development.  There is no clear argument  for 
or against such an hypothesis, and one reason for this specu- 
lation is missing experimental evidence that 3'/t~ cells require 
positive selection by ligands  on thymic epithelium. 
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